Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?

Purpose The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone. Methods Women who had a MSAFP test fol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of gynecology and obstetrics 2016-04, Vol.293 (4), p.767-770
Hauptverfasser: Sharony, Reuven, Dayan, Dikla, Kidron, Debora, Manor, Mira, Berkovitz, Arie, Biron-Shental, Tal, Maymon, Ron
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 770
container_issue 4
container_start_page 767
container_title Archives of gynecology and obstetrics
container_volume 293
creator Sharony, Reuven
Dayan, Dikla
Kidron, Debora
Manor, Mira
Berkovitz, Arie
Biron-Shental, Tal
Maymon, Ron
description Purpose The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone. Methods Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared. Results 166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption. Conclusion Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC.
doi_str_mv 10.1007/s00404-015-3905-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1774526069</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261525731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</originalsourceid><addsrcrecordid>eNp1kV9rFTEQxYNU7LX6AXyRQF_6sjr5f_eplNKrhYI-6HNIk9masrvZJrvSfnuzbFUQhEBmOL-cIXMIecfgAwMwHwuABNkAU41oQTXtC7JjUvAGDGNHZAftWoM2x-R1KfcAjO_3-hU55loqITTbkcfrQucfSLObY6Kpo4ObMY-upwXzMtA5UTeMMc3R065fYqAXh6-0LBPmmPIqb1yPP7Ev1NVDp4wh-rnK1a82d6Mb_RP1aZj66NdBYzl_Q152ri_49vk-Id8PV98uPzc3Xz5dX17cNF5KPjeKB9HqDttOBQAXOsM1dwJF_X9gTgajOrHXTu5RaOFuhTe-1j6IugfulTghZ5vvlNPDgmW2Qywe-96NmJZimTFScQ26rejpP-h9WtZdFMu5ZoorI1il2Eb5nErJ2Nkpx8HlJ8vArrHYLRZbY7FrLHZ1fv_svNwOGP68-J1DBfgGlCqNd5j_jv6_6y-IXpfu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2261525731</pqid></control><display><type>article</type><title>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Sharony, Reuven ; Dayan, Dikla ; Kidron, Debora ; Manor, Mira ; Berkovitz, Arie ; Biron-Shental, Tal ; Maymon, Ron</creator><creatorcontrib>Sharony, Reuven ; Dayan, Dikla ; Kidron, Debora ; Manor, Mira ; Berkovitz, Arie ; Biron-Shental, Tal ; Maymon, Ron</creatorcontrib><description>Purpose The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone. Methods Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared. Results 166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption. Conclusion Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC.</description><identifier>ISSN: 0932-0067</identifier><identifier>EISSN: 1432-0711</identifier><identifier>DOI: 10.1007/s00404-015-3905-9</identifier><identifier>PMID: 26453361</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; alpha-Fetoproteins - analysis ; Amniocentesis - methods ; Amniotic Fluid - chemistry ; Biomarkers - analysis ; Biomarkers - blood ; Endocrinology ; Female ; Fetal Growth Retardation - blood ; Gynecology ; Human Genetics ; Humans ; Maternal Serum Screening Tests ; Maternal-Fetal Medicine ; Medicine ; Medicine &amp; Public Health ; Obstetrics/Perinatology/Midwifery ; Pregnancy - blood ; Pregnancy Complications ; Prenatal development ; Retrospective Studies</subject><ispartof>Archives of gynecology and obstetrics, 2016-04, Vol.293 (4), p.767-770</ispartof><rights>Springer-Verlag Berlin Heidelberg 2015</rights><rights>Archives of Gynecology and Obstetrics is a copyright of Springer, (2015). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</citedby><cites>FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00404-015-3905-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00404-015-3905-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26453361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharony, Reuven</creatorcontrib><creatorcontrib>Dayan, Dikla</creatorcontrib><creatorcontrib>Kidron, Debora</creatorcontrib><creatorcontrib>Manor, Mira</creatorcontrib><creatorcontrib>Berkovitz, Arie</creatorcontrib><creatorcontrib>Biron-Shental, Tal</creatorcontrib><creatorcontrib>Maymon, Ron</creatorcontrib><title>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</title><title>Archives of gynecology and obstetrics</title><addtitle>Arch Gynecol Obstet</addtitle><addtitle>Arch Gynecol Obstet</addtitle><description>Purpose The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone. Methods Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared. Results 166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption. Conclusion Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC.</description><subject>Adult</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Amniocentesis - methods</subject><subject>Amniotic Fluid - chemistry</subject><subject>Biomarkers - analysis</subject><subject>Biomarkers - blood</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Fetal Growth Retardation - blood</subject><subject>Gynecology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Maternal Serum Screening Tests</subject><subject>Maternal-Fetal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Obstetrics/Perinatology/Midwifery</subject><subject>Pregnancy - blood</subject><subject>Pregnancy Complications</subject><subject>Prenatal development</subject><subject>Retrospective Studies</subject><issn>0932-0067</issn><issn>1432-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kV9rFTEQxYNU7LX6AXyRQF_6sjr5f_eplNKrhYI-6HNIk9masrvZJrvSfnuzbFUQhEBmOL-cIXMIecfgAwMwHwuABNkAU41oQTXtC7JjUvAGDGNHZAftWoM2x-R1KfcAjO_3-hU55loqITTbkcfrQucfSLObY6Kpo4ObMY-upwXzMtA5UTeMMc3R065fYqAXh6-0LBPmmPIqb1yPP7Ev1NVDp4wh-rnK1a82d6Mb_RP1aZj66NdBYzl_Q152ri_49vk-Id8PV98uPzc3Xz5dX17cNF5KPjeKB9HqDttOBQAXOsM1dwJF_X9gTgajOrHXTu5RaOFuhTe-1j6IugfulTghZ5vvlNPDgmW2Qywe-96NmJZimTFScQ26rejpP-h9WtZdFMu5ZoorI1il2Eb5nErJ2Nkpx8HlJ8vArrHYLRZbY7FrLHZ1fv_svNwOGP68-J1DBfgGlCqNd5j_jv6_6y-IXpfu</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Sharony, Reuven</creator><creator>Dayan, Dikla</creator><creator>Kidron, Debora</creator><creator>Manor, Mira</creator><creator>Berkovitz, Arie</creator><creator>Biron-Shental, Tal</creator><creator>Maymon, Ron</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160401</creationdate><title>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</title><author>Sharony, Reuven ; Dayan, Dikla ; Kidron, Debora ; Manor, Mira ; Berkovitz, Arie ; Biron-Shental, Tal ; Maymon, Ron</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Amniocentesis - methods</topic><topic>Amniotic Fluid - chemistry</topic><topic>Biomarkers - analysis</topic><topic>Biomarkers - blood</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Fetal Growth Retardation - blood</topic><topic>Gynecology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Maternal Serum Screening Tests</topic><topic>Maternal-Fetal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Obstetrics/Perinatology/Midwifery</topic><topic>Pregnancy - blood</topic><topic>Pregnancy Complications</topic><topic>Prenatal development</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharony, Reuven</creatorcontrib><creatorcontrib>Dayan, Dikla</creatorcontrib><creatorcontrib>Kidron, Debora</creatorcontrib><creatorcontrib>Manor, Mira</creatorcontrib><creatorcontrib>Berkovitz, Arie</creatorcontrib><creatorcontrib>Biron-Shental, Tal</creatorcontrib><creatorcontrib>Maymon, Ron</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharony, Reuven</au><au>Dayan, Dikla</au><au>Kidron, Debora</au><au>Manor, Mira</au><au>Berkovitz, Arie</au><au>Biron-Shental, Tal</au><au>Maymon, Ron</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</atitle><jtitle>Archives of gynecology and obstetrics</jtitle><stitle>Arch Gynecol Obstet</stitle><addtitle>Arch Gynecol Obstet</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>293</volume><issue>4</issue><spage>767</spage><epage>770</epage><pages>767-770</pages><issn>0932-0067</issn><eissn>1432-0711</eissn><abstract>Purpose The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone. Methods Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared. Results 166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption. Conclusion Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26453361</pmid><doi>10.1007/s00404-015-3905-9</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0932-0067
ispartof Archives of gynecology and obstetrics, 2016-04, Vol.293 (4), p.767-770
issn 0932-0067
1432-0711
language eng
recordid cdi_proquest_miscellaneous_1774526069
source MEDLINE; SpringerNature Journals
subjects Adult
alpha-Fetoproteins - analysis
Amniocentesis - methods
Amniotic Fluid - chemistry
Biomarkers - analysis
Biomarkers - blood
Endocrinology
Female
Fetal Growth Retardation - blood
Gynecology
Human Genetics
Humans
Maternal Serum Screening Tests
Maternal-Fetal Medicine
Medicine
Medicine & Public Health
Obstetrics/Perinatology/Midwifery
Pregnancy - blood
Pregnancy Complications
Prenatal development
Retrospective Studies
title Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A27%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20ratio%20of%20maternal%20serum%20to%20amniotic%20fluid%20AFP%20superior%20to%20serum%20levels%20as%20a%20predictor%20of%20pregnancy%20complications?&rft.jtitle=Archives%20of%20gynecology%20and%20obstetrics&rft.au=Sharony,%20Reuven&rft.date=2016-04-01&rft.volume=293&rft.issue=4&rft.spage=767&rft.epage=770&rft.pages=767-770&rft.issn=0932-0067&rft.eissn=1432-0711&rft_id=info:doi/10.1007/s00404-015-3905-9&rft_dat=%3Cproquest_cross%3E2261525731%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2261525731&rft_id=info:pmid/26453361&rfr_iscdi=true